Cite
HARVARD Citation
Accorsi Buttini, E. et al. (n.d.). PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA. HemaSphere. pp. 2079-2080. [Online].